Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$60.0 - $68.46 $4.5 Million - $5.13 Million
-75,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$56.65 - $64.55 $4.25 Million - $4.84 Million
75,000 New
75,000 $4.37 Million
Q1 2019

May 15, 2019

SELL
$62.53 - $70.05 $21.9 Million - $24.5 Million
-350,000 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$60.54 - $79.0 $21.2 Million - $27.7 Million
350,000 New
350,000 $21.9 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Voleon Capital Management LP Portfolio

Follow Voleon Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voleon Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Voleon Capital Management LP with notifications on news.